Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition.

Adult Aged Dietary Fats / administration & dosage Fatty Acids / administration & dosage Humans Male Middle Aged Prospective Studies Prostatic Neoplasms / epidemiology Risk Factors
individual fatty acids prospective prostate cancer tumor subtypes

Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 14 01 2019
revised: 11 02 2019
accepted: 13 02 2019
pubmed: 27 2 2019
medline: 15 2 2020
entrez: 27 2 2019
Statut: ppublish

Résumé

The associations of individual dietary fatty acids with prostate cancer risk have not been examined comprehensively. We examined the prospective association of individual dietary fatty acids with prostate cancer risk overall, by tumor subtypes, and prostate cancer death. 142,239 men from the European Prospective Investigation into Cancer and Nutrition who were free from cancer at recruitment were included. Dietary intakes of individual fatty acids were estimated using center-specific validated dietary questionnaires at baseline and calibrated with 24-h recalls. Multivariable Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). After an average follow-up of 13.9 years, 7,036 prostate cancer cases and 936 prostate cancer deaths were ascertained. Intakes of individual fatty acids were not related to overall prostate cancer risk. There was evidence of heterogeneity in the association of some short chain saturated fatty acids with prostate cancer risk by tumor stage (p

Identifiants

DOI: 10.1002/ijc.32233 PMID: 30807653 PMC: PMC6899744
pubmed: 30807653
doi: 10.1002/ijc.32233
pmc: PMC6899744
doi:

Substances chimiques

Dietary Fats 0
Fatty Acids 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-57

Subventions

Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : C570/A16491
Pays : United Kingdom
Organisme : Medical Research Council
ID : 14136
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

Br J Nutr. 2012 Feb;107(3):405-15
pubmed: 21767448
Am J Clin Nutr. 1996 Dec;64(6):850-5
pubmed: 8942407
Int J Cancer. 2012 Sep 15;131(6):1396-406
pubmed: 22120496
Br J Cancer. 2008 May 6;98(9):1574-81
pubmed: 18382426
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Cancer Res. 2016 Apr 15;76(8):2288-2300
pubmed: 26921328
Lancet Oncol. 2014 Oct;15(11):e484-92
pubmed: 25281467
Int J Epidemiol. 1997;26 Suppl 1:S1-5
pubmed: 9126528
Int J Cancer. 2018 Jun 1;142(11):2207-2214
pubmed: 29315549
BMC Med. 2017 Jul 13;15(1):115
pubmed: 28701188
Nat Rev Urol. 2010 Aug;7(8):442-53
pubmed: 20647991
BMJ. 2016 Nov 23;355:i5796
pubmed: 27881409
Am J Clin Nutr. 2004 Sep;80(3):550-9
pubmed: 15321792
JAMA Intern Med. 2013 Jul 22;173(14):1318-26
pubmed: 23752662
J Clin Oncol. 1999 Oct;17(10):3291-8
pubmed: 10506632
Public Health Nutr. 2002 Dec;5(6B):1329-45
pubmed: 12639236
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):697-707
pubmed: 23549401
Am J Epidemiol. 2006 Jun 1;163(11):1053-64
pubmed: 16624970
Am J Epidemiol. 2012 Aug 1;176(3):240-52
pubmed: 22781428
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):930-7
pubmed: 18398033
Cancer Control. 2007 Jan;14(1):78-85
pubmed: 17242674
Cancer Res. 2008 Apr 15;68(8):3066-73
pubmed: 18413778
Nature. 2017 Jan 5;541(7635):41-45
pubmed: 27974793
J Urol. 2008 May;179(5):1668-75
pubmed: 18343442
Public Health Nutr. 2003 Jun;6(4):407-13
pubmed: 12795830
Cancer. 1999 Sep 15;86(6):1019-27
pubmed: 10491529
J Natl Cancer Inst. 1993 Oct 6;85(19):1571-9
pubmed: 8105097
Eur J Cancer. 2016 Dec;69:61-69
pubmed: 27816833
JAMA Intern Med. 2016 Aug 1;176(8):1134-45
pubmed: 27379574
Am J Clin Nutr. 2010 Jun;91(6):1769-76
pubmed: 20427733
Am J Clin Nutr. 2004 Jul;80(1):204-16
pubmed: 15213050
Br J Cancer. 2016 Aug 23;115(5):624-31
pubmed: 27490808
J Natl Cancer Inst. 2014 Sep 10;106(9):null
pubmed: 25210201

Auteurs

Aurora Perez-Cornago (A)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
ORCID: 0000-0002-5652-356X

Inge Huybrechts (I)

Dietary Exposure Assessment Group, International Agency for Research on Cancer, Lyon, France.

Paul N Appleby (PN)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Julie A Schmidt (JA)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
ORCID: 0000-0002-7733-8750

Francesca L Crowe (FL)

Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

Kim Overvad (K)

Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus C, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Tilman Kühn (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Verena Katzke (V)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Anna Karakatsani (A)

Hellenic Health Foundation, Athens, Greece.
Department of Pulmonary Medicine, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.

Eleni Peppa (E)

Hellenic Health Foundation, Athens, Greece.

Sara Grioni (S)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
ORCID: 0000-0002-8008-5096

Rosario Tumino (R)

Department of Cancer Registry and Histopathology, "Civic - M.P. Arezzo" Hospital ASP, Ragusa, Italy.

H Bas Bueno-de-Mesquita (HB)

Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom.
Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Nerea Larrañaga (N)

Department of Basque Regional Health, Public Health Division of Gipuzkoa-BIODONOSTIA, Guipúzcoa, Spain.
CIBER of Epidemiology and Public Health, Madrid, Spain.

Maria-Jose Sánchez (MJ)

CIBER of Epidemiology and Public Health, Madrid, Spain.
Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

J Ramón Quirós (JR)

Public Health Directorate, Asturias, Spain.

Eva Ardanaz (E)

CIBER of Epidemiology and Public Health, Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

María-Dolores Chirlaque (MD)

CIBER of Epidemiology and Public Health, Madrid, Spain.
Department of Epidemiology, Regional Health Council, Murcia, Spain.
Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.

Anders Bjartell (A)

Department of Translational Medicine, Medical Faculty, Lund University, Malmö, Sweden.
Department of Urology, Skåne University Hospital, Malmö, Sweden.

Peter Wallström (P)

Nutrition Epidemiology Research Group, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Clinical Research Centre, Malmö University Hospital, Malmö, Sweden.

Veronique Chajes (V)

Department of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
ORCID: 0000-0003-1297-3064

Konstantinos K Tsilidis (KK)

Department of Hygiene and Epidemiology, University of Ioannina, School of Medicine, Ioannina, Greece.
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
ORCID: 0000-0002-8452-8472

Dagfinn Aune (D)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Department of Nutrition, Bjørknes University College, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Elio Riboli (E)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Ruth C Travis (RC)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Timothy J Key (TJ)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Intake of individual fatty acids and risk of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Intake of individual fatty acids and risk of...
questionsmedicales.fr › Aliments et boissons › Aliments › Matières grasses alimentaires › Intake of individual fatty acids and risk of...
questionsmedicales.fr › Lipides › Acides gras › Intake of individual fatty acids and risk of...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Intake of individual fatty acids and risk of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Intake of individual fatty acids and risk of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Intake of individual fatty acids and risk of...
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Intake of individual fatty acids and risk of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Intake of individual fatty acids and risk of...